Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News FDA declines approval for Sunovion’s ADHD drug dasotraline, citing need for more data In a regulatory setback, the U.S. Food and Drug Administration (FDA) has decided not to approve Sunovion Pharmaceuticals’… bypharmanewsdailySeptember 2, 2018
